Vaccine Scheduler

Pneumococcal Disease: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Weeks	Months												Years
	6	2	3	4	5	6	10	11	12	13	14	15	18	2-17	18	50	59	60	64	65	75	≥ 76
Austria			PCV15		PCV15				PCV15									PCV15 or 20 and PPSV23

Belgium		PCV13 or PCV15		PCV13 or PCV15					PCV13 or PCV15						PCV20					PCV20

Bulgaria	PCV10 or PCV15		PCV10 or PCV15¹						PCV10 or PCV15²						PCV13					PCV13

Croatia		PCV10		PCV10					PCV10						PCV13+PPSV23³

Cyprus			PCV15 or PCV20		PCV15 or PCV20				PCV15 or PCV20⁴						PCV20					PCV20

Czechia		PCV13 or PCV15 or PCV20	PCV13 or PCV15 or PCV20		PCV13 or PCV15 or PCV20					PCV20					PCV or PPSV23⁵					PCV15+PPSV23 or PCV20

Denmark			PCV13		PCV13				PCV13

Estonia															PCV13/PCV15 + PPSV23 or PCV20⁶						PCV13 or PCV15 or PCV20 or PPSV23

Finland			PCV10		PCV10				PCV10						PCV20⁷

France		PCV13 or PCV15		PCV13 or PCV15				PCV13 or PCV15							PCV20					PCV20

Germany		PCV13 or PCV15		PCV13 or PCV15				PCV13 or PCV15						PCV13/15+PPSV23	PCV20			PCV20

Greece		PCV15 or PCV20		PCV15 or PCV20					PCV15 or PCV20⁸						PCV20					PCV20

Hungary		PCV15		PCV15					PCV15						PCV15+PPSV23 or PCV20					PCV20

Iceland			PCV15		PCV15				PCV15						PCV13/PCV15 + PPSV23 or PCV20					PCV20 or PPSV23

Ireland		PCV13 or PCV15				PCV13 or PCV15				PCV13 or PCV15				PPSV23⁹

Italy		PCV13		PCV13			PCV13								PCV13+PPSV23					PCV13+PPSV23¹⁰

Latvia		PCV15		PCV15					PCV15						PCV13 or PCV15 or PCV20					PCV13 or PCV15 or PCV20

Liechtenstein		PCV13 or PCV15		PCV13 or PCV15					PCV13 or PCV15						PCV15 or PCV20					PCV15 or PCV20

Lithuania		PCV15		PCV15					PCV15¹¹						PCV20						PCV20

Luxembourg		PCV10 or PCV13	PCV¹²	PCV10 or PCV13				PCV10 or PCV13				PCV¹³			PCV20¹⁴					PCV20¹⁵

Malta		PCV10		PCV10					PCV10											PCV20¹⁶

Netherlands			PCV15		PCV15				PCV15						PCV13/15+PPSV23¹⁷					PCV20

Norway			PCV13		PCV13				PCV13						PCV20 or PPSV23¹⁸					PCV20 or PPSV23

Poland		PCV10		PCV10						PCV10						PCV13+PPSV23				PCV13+PPSV23

Portugal		PCV20		PCV20					PCV20						PCV20+PPSV23					PPSV23

Romania		PCV13		PCV13				PCV13							PCV13/PCV15 + PPSV23 or PCV20					PCV13 or PCV15 or PCV20 or PPSV23

Slovakia			PCV10 or PCV13 or PCV15		PCV10 or PCV13 or PCV15			PCV10 or PCV13 or PCV15¹⁹									PCV²⁰

Slovenia			PCV20		PCV20	PCV20		PCV20							PPSV23					PPSV23

Spain		PCV13 or PCV15 or PCV20²¹		PCV13 or PCV15 or PCV20				PCV13 or PCV15 or PCV20							PCV13/15+PPSV23²²					PCV13/15+PPSV23²³

Sweden			PCV15		PCV15				PCV15						PCV20 or PPSV23²⁴						PPSV23²⁵

Footnotes:

3-dose schedule, divided as 2 doses for primary immunization from the 6th and 14th weeks (around 3 months) postpartum and one dose for reimmunization from 12 months postpartum.
Not earlier than 6 months after the previous dose
PPSV23 alone is also an option depending on the medical conditions.
When PCV20 is used, the recommended schedule consists of 3 primary doses + 1 booster dose (3+1).
Any PCV or PPSV23. Vaccination is especially recommended for people with chronic lung disease (includes moderate and severe bronchial asthma), with long-term medical treatment; persons with heart disease and/or large vessels with long-term systemic medical treatment, such as hypertension; people with chronic kidney and liver disease; patients with diabetes mellitus; patients with an immune disorder system (eg patients with immunosuppressive treatment (steroids, HIV infections, etc.) and asplenia / hyposplenia; patients with anticancer treatment; patients before / after solid organ and / or bone marrow transplantation; people with severe obesity (BMI over 40 kg / m2) and persons over 65 years of age.
Risk groups list is published here: https://terviseamet.ee/sites/default/files/documents/2024-07/pneumo-_ja_meningokokk-nakkuse_korge_riskiga_riskiruhmad.pdf
for more information on pneumococcal vaccination and target groups refer to https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/pneumokokkirokotteet/riskiryhmien-pneumokokkirokotukset
When PCV20 is selected, the recommended schedule consists of 3 primary doses + 1 booster dose (3+1).
Please refer to https://www.hse.ie/eng/health/immunisation/pubinfo/adult/pneumo/#Who%20should%20be%20vaccinated%20with%20PPV23%20Pneumococcal%20vaccine? for a full listing of people in at-risk groups
one dose of PCV13 at 65 years and one dose PPSV after at least 8 weeks
Can be administered concomitantly with MMR
For premature infants (born before 33 weeks) or with a birthweight <1500g, a 3+1 schedule is recommended
For those not previously vaccinated with an increased risk of severe disease.
for those at increased risk of complications or severe disease
For people aged 65 years of age, update to the pneumococcal recommendations based on prior vaccination. please refer to the full recommendation available here: https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
PCV20 is also recommended as a specific recommendation for medical risk groups (from 6 weeks to 64 years of age).
https://www.rivm.nl/pneumokokken/pneumokokkenprik
Fully funded for patients with HIV infections, stem cell transplantations and for anatomical or functional asplenia. Not funded (NF) for other risk groups.
https://www.ockovaniechrani.sk/#/ockovaci-kalendar
Vaccination is also mandatory for persons placed in social service facilities. Vaccination is recommended for persons under medical supervision, regardless of age, with serious chronic diseases of the respiratory tract, cardiovascular system, metabolic, renal and immune disorders, persons with functional or anatomical asplenia prior to splenectomy, and persons 59 years of age and older. https://www.uvzsr.sk/web/uvz/povinne-a-odporucane-ockovanie-podla-dosiahnuteho-veku-a-rizika-nakazy-v-slovenskej-republike-na-rok-2016
More information: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_Todalavida.pdf
PPSV or sequential schedule (PCV+PPSV) depend on pathology and available vaccines.
PCV is recommended in some regions.
More information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-pneumokockvaccination-/
https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/nationella-vaccinationsprogram/program-for-riskgrupper/